This increased sensitivity of the last-generation assays has dramatically reduced the risk of HCV transmission by blood components by reducing the window period from 82 days (5) to 66 days (3, 12)
This increased sensitivity of the last-generation assays has dramatically reduced the risk of HCV transmission by blood components by reducing